Consulting giant McKinsey & Company will pay $650 million to settle US criminal charges it collaborated with Purdue Pharma to intentionally misbrand opioids, according to a court filing Friday.
McKinsey “knowingly and intentionally” conspired with Purdue to “aid and abet the misbranding of prescription drugs… without valid prescriptions,” according to a US Department of Justice document describing a deferred prosecution that will expire in five years if McKinsey meets the conditions.
Add Comment